May 31, 2016 / 10:32 PM / in 2 years

BRIEF-Valeant Pharmaceuticals provides update on regulatory matters

May 31 (Reuters) - Valeant Pharmaceuticals International Inc :

* On issuance of MCTOS,alternative information guidelines,confirms co has fulfilled intentions on compliance with alternative info guidelines

* Autorité des marchés financiers issued a customary management cease trade order on May 17, 2016 relating to trading in securities of co by co’s CEO and CFO

* Valeant Pharmaceuticals to hold conference call on June 7, 2016

* There have been no material changes to information relating to company’s delay in making Canadian required filings Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below